+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Competent Cells - Global Market Trajectory & Analytics

  • ID: 4804215
  • Report
  • September 2020
  • Region: Global
  • 176 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • ILLUMINA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • MORE
Global Competent Cells Market to Reach $3 Billion by 2027

Amid the COVID-19 crisis, the global market for Competent Cells estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at a CAGR of 8.8% over the period 2020-2027. Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 7-year period.

The U. S. Market is Estimated at $490.7 Million, While China is Forecast to Grow at 8.2% CAGR

The Competent Cells market in the U. S. is estimated at US$490.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$519.3 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.2% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR. We bring years of research experience to this 7th edition of our report. The 176-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Merck KgaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • ILLUMINA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • MORE
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
  • Clean-Label Starch Innovations
  • Chemically Competent Cells Segment Dominate in North America
  • Drivers & Restrains Summarized for Competent Cells Market
  • Cloning is Expected to Take the Largest Share of Competent Cells Market
  • Competent Cells Growth Outlook
  • Competent Cells Application Trends
  • Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market
  • Leading Players in competent cells market
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • Advancements in Molecular Cloning Drives Competent Cell Market
  • Drivers and Restraints Summarised
  • SGI-DNA Inc has Launched Vmax™ Express Chemically Competent Cells .
  • Increasing Research on Cloning Demands Competent Cells Requirement
  • Increasing Intensity of Research and Technological Advancements Drives Market
  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
  • As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells
  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
  • As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells
  • Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins
  • Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells
  • Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells
  • Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth
  • Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods
  • Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method
  • Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells
  • Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth
  • Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery
  • Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030
  • Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Competent Cells Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Competent Cells Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Chemically Competent Cells (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 4: Chemically Competent Cells (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Electrocompetent Cells (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 6: Electrocompetent Cells (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Cloning (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 8: Cloning (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 9: Protein Expression (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 10: Protein Expression (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
  • TABLE 11: Other Applications (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 12: Other Applications (Application) Distribution of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 13: Pharmaceutical & Biotechnology Companies (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
  • TABLE 14: Pharmaceutical & Biotechnology Companies (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027
  • TABLE 15: Academic Research Institutes (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • TABLE 16: Academic Research Institutes (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 17: Contract Research Organizations (CROs) (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • TABLE 18: Contract Research Organizations (CROs) (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Competent Cells Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 19: United States Competent Cells Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
  • TABLE 20: United States Competent Cells Market Share Breakdown by Type: 2020 VS 2027
  • TABLE 21: United States Competent Cells Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
  • TABLE 22: Competent Cells Market Share Breakdown in the United States by Application: 2020 VS 2027
  • TABLE 23: United States Competent Cells Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 24: Competent Cells Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
  • TABLE 25: Canadian Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
  • TABLE 26: Competent Cells Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
  • TABLE 27: Canadian Competent Cells Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
  • TABLE 28: Canadian Competent Cells Market Share Analysis by Application: 2020 VS 2027
  • TABLE 29: Canadian Competent Cells Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 30: Canadian Competent Cells Market Share Analysis by End-Use: 2020 VS 2027
JAPAN
  • TABLE 31: Japanese Market for Competent Cells: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
  • TABLE 32: Japanese Competent Cells Market Share Analysis by Type: 2020 VS 2027
  • TABLE 33: Japanese Demand Estimates and Forecasts for Competent Cells in US$ Thousand by Application: 2020 to 2027
  • TABLE 34: Competent Cells Market Share Shift in Japan by Application: 2020 VS 2027
  • TABLE 35: Japanese Demand Estimates and Forecasts for Competent Cells in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 36: Competent Cells Market Share Shift in Japan by End-Use: 2020 VS 2027
CHINA
  • TABLE 37: Chinese Competent Cells Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
  • TABLE 38: Chinese Competent Cells Market by Type: Percentage Breakdown of Sales for 2020 and 2027
  • TABLE 39: Chinese Demand for Competent Cells in US$ Thousand by Application: 2020 to 2027
  • TABLE 40: Chinese Competent Cells Market Share Breakdown by Application: 2020 VS 2027
  • TABLE 41: Chinese Demand for Competent Cells in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 42: Chinese Competent Cells Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European Competent Cells Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 43: European Competent Cells Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
  • TABLE 44: European Competent Cells Market Share Shift by Region/Country: 2020 VS 2027
  • TABLE 45: European Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
  • TABLE 46: European Competent Cells Market Share Breakdown by Type: 2020 VS 2027
  • TABLE 47: European Competent Cells Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
  • TABLE 48: European Competent Cells Market Share Analysis by Application: 2020 VS 2027
  • TABLE 49: European Competent Cells Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
  • TABLE 50: European Competent Cells Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
  • TABLE 51: Competent Cells Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
  • TABLE 52: French Competent Cells Market Share Analysis by Type: 2020 VS 2027
  • TABLE 53: Competent Cells Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
  • TABLE 54: French Competent Cells Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • TABLE 55: Competent Cells Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
  • TABLE 56: French Competent Cells Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
  • TABLE 57: Competent Cells Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
  • TABLE 58: German Competent Cells Market Share Breakdown by Type: 2020 VS 2027
  • TABLE 59: Competent Cells Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
  • TABLE 60: Competent Cells Market Share Distribution in Germany by Application: 2020 VS 2027
  • TABLE 61: Competent Cells Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
  • TABLE 62: Competent Cells Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
  • TABLE 63: Italian Competent Cells Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
  • TABLE 64: Italian Competent Cells Market by Type: Percentage Breakdown of Sales for 2020 and 2027
  • TABLE 65: Italian Demand for Competent Cells in US$ Thousand by Application: 2020 to 2027
  • TABLE 66: Italian Competent Cells Market Share Breakdown by Application: 2020 VS 2027
  • TABLE 67: Italian Demand for Competent Cells in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 68: Italian Competent Cells Market Share Breakdown by End-Use: 2020 VS 2027
UNITED KINGDOM
  • TABLE 69: United Kingdom Market for Competent Cells: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
  • TABLE 70: United Kingdom Competent Cells Market Share Analysis by Type: 2020 VS 2027
  • TABLE 71: United Kingdom Demand Estimates and Forecasts for Competent Cells in US$ Thousand by Application: 2020 to 2027
  • TABLE 72: Competent Cells Market Share Shift in the United Kingdom by Application: 2020 VS 2027
  • TABLE 73: United Kingdom Demand Estimates and Forecasts for Competent Cells in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 74: Competent Cells Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
  • TABLE 75: Rest of Europe Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
  • TABLE 76: Rest of Europe Competent Cells Market Share Breakdown by Type: 2020 VS 2027
  • TABLE 77: Rest of Europe Competent Cells Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
  • TABLE 78: Rest of Europe Competent Cells Market Share Analysis by Application: 2020 VS 2027
  • TABLE 79: Rest of Europe Competent Cells Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
  • TABLE 80: Rest of Europe Competent Cells Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
  • TABLE 81: Competent Cells Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
  • TABLE 82: Asia-Pacific Competent Cells Market Share Analysis by Type: 2020 VS 2027
  • TABLE 83: Competent Cells Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
  • TABLE 84: Asia-Pacific Competent Cells Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • TABLE 85: Competent Cells Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
  • TABLE 86: Asia-Pacific Competent Cells Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
  • TABLE 87: Rest of World Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
  • TABLE 88: Competent Cells Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
  • TABLE 89: Rest of World Competent Cells Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
  • TABLE 90: Rest of World Competent Cells Market Share Analysis by Application: 2020 VS 2027
  • TABLE 91: Rest of World Competent Cells Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 92: Rest of World Competent Cells Market Share Analysis by End-Use: 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
3 of 3
  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • GENSCRIPT BIOTECH CORPORATION
  • ILLUMINA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • PROMEGA CORPORATION
  • QIAGEN NV
  • TAKARA BIO
  • THERMO FISHER SCIENTIFIC
  • ZYMO RESEARCH CORPOR
Note: Product cover images may vary from those shown
Adroll
adroll